BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29243285)

  • 1. Cholesterol embolization syndrome: An under-recognized entity in cardiovascular interventions.
    Agrawal A; Ziccardi MR; Witzke C; Palacios I; Rangaswami J
    J Interv Cardiol; 2018 Jun; 31(3):407-415. PubMed ID: 29243285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study.
    Fukumoto Y; Tsutsui H; Tsuchihashi M; Masumoto A; Takeshita A;
    J Am Coll Cardiol; 2003 Jul; 42(2):211-6. PubMed ID: 12875753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol embolization syndrome.
    Saric M; Kronzon I
    Curr Opin Cardiol; 2011 Nov; 26(6):472-9. PubMed ID: 21993354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol-embolization syndrome: current perspectives.
    Ozkok A
    Vasc Health Risk Manag; 2019; 15():209-220. PubMed ID: 31371977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Atheroembolic renal disease: a diagnostic challenge].
    Scolari F; Turina S; Venturelli C; Dallera N; Valerio F; Mazzola G; Faberi E; Sottini L; Kenou R
    Recenti Prog Med; 2008; 99(7-8):377-88. PubMed ID: 18751618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Atheroembolic renal disease: analysis of clinical and therapeutic factors that influence its progression].
    Gutiérrez Solís E; Morales E; Rodríguez Jornet A; Andreu FJ; Rivera F; Vozmediano C; Gutiérrez E; Igarzábal A; Enguita AB; Praga M
    Nefrologia; 2010; 30(3):317-23. PubMed ID: 20414329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Unusual Presentation of Cholesterol Embolization Syndrome.
    Abdelazeem B; Ayad S; Osman AF; Gjeka R; Kunadi A
    Cureus; 2021 Aug; 13(8):e16993. PubMed ID: 34540395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case Report: Atheroembolic renal disease in a 72-year-old patient through coronary intervention after myocardial infarction.
    Herzog AL; Wanner C
    Hemodial Int; 2008 Oct; 12(4):406-11. PubMed ID: 19090862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atheroembolic renal disease.
    Saleem S; Lakkis FG; Martínez-Maldonado M
    Semin Nephrol; 1996 Jul; 16(4):309-18. PubMed ID: 8829269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subacute renal failure in diabetic nephropathy due to endocapillary glomerulonephritis and cholesterol embolization.
    Rivera F; Vazmediano C; Gonzalez-Lopez L; Carrano A; Blanco J
    J Nephrol; 2008; 21(4):615-20. PubMed ID: 18651554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Atheroembolism renal disease: diagnosis and etiologic factors].
    Granata A; Insalaco M; Di Pietro F; Di Rosa S; Romano G; Scuderi R
    Clin Ter; 2012 Jul; 163(4):313-22. PubMed ID: 23007816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol crystal embolization.
    Morales JM; Gonzalez E
    Blood Purif; 2006; 24(5-6):431-2. PubMed ID: 16940712
    [No Abstract]   [Full Text] [Related]  

  • 13. Atheromatous embolization.
    Liew YP; Bartholomew JR
    Vasc Med; 2005 Nov; 10(4):309-26. PubMed ID: 16444859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cholesterol embolism--a serious systemic disease].
    Palmgren E; Hartford M; Herlitz H
    Lakartidningen; 2000 Mar; 97(11):1263-6. PubMed ID: 10771545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis and prognosis of atheroembolic disease].
    Rodríguez Jornet A; Andreu FJ; Orellana R; Ibeas J; Vallvé M; Esteve V; Valenzuela MP; García García M
    Nefrologia; 2005; 25(6):637-44. PubMed ID: 16514904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol embolization syndrome induced by thrombolytic therapy.
    Hitti WA; Wali RK; Weinman EJ; Drachenberg C; Briglia A
    Am J Cardiovasc Drugs; 2008; 8(1):27-34. PubMed ID: 18303935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal cholesterol embolic disease. Case report and review of the literature.
    Lye WC; Cheah JS; Sinniah R
    Am J Nephrol; 1993; 13(6):489-93. PubMed ID: 8141186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for atherosclerotic cardiovascular outcomes in different arterial territories.
    Kannel WB
    J Cardiovasc Risk; 1994 Dec; 1(4):333-9. PubMed ID: 7621317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Atheroembolic disease and pulmonary haemorrhage].
    De La Prada Alvarez FJ; Blanco Huelga C; Prados Gallardo AM; Uriol Rivera M
    An Med Interna; 2004 May; 21(5):231-4. PubMed ID: 15176925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolytic-associated cholesterol emboli syndrome: case report and literature review.
    Geraets DR; Hoehns JD; Burke TG; Grover-McKay M
    Pharmacotherapy; 1995; 15(4):441-50. PubMed ID: 7479196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.